Optimizing your value with payers

O'Neill, Mike
July 2011
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p28
The article offers information in achieving successful negotiations with payers in the pharmaceutical industry in the U.S. For the pharmaceutical affiliate general manager, market access director, or brand manager, defining success in the negotiation begins well ahead of the initial appointment to tackle price level and reimbursement coverage. It discusses marketing authorization and eventual negotiations in the industry.


Related Articles

  • NCPA appeals for higher rates for chemo drugs.  // Drug Topics;1/26/2004, Vol. 148 Issue 2, p10 

    Reports on the complaint over the new reduced reimbursement rates for Medicare Part B drugs in the U.S. Implications for the pharmaceutical industry; Call for the revision of the payment rates to accurately reflect pharmacies' cost.

  • Medicare not likely to cover bevacizumab treatment. Williams, George A. // Ophthalmology Times;2/15/2006, Vol. 31 Issue 4, p1 

    The article reports on the possibility that Medicare will not reimburse expenses for the use of bevacizumab, an off-label treatment for wet age-related macular degeneration (AMD). The therapy draws much attention in the U.S. due to its potential for improving visual acuity in patients with wet...

  • Medicare Rx discount cards end.  // Drug Topics;6/5/2006, Vol. 150 Issue 11, p6 

    The article reports on the announcement of the U.S. Centers for Medicare and Medicaid Services (CMS) reminding pharmacist on the end of the Medicare-approved Drug Discount Card program on May 15, 2006. The agency has asked discount card sponsors to cooperate with pharmacies to settle claims...

  • Insurance Coverage and Pharmaceutical Industry Innovation. Golec, Joseph; Vernon, John // Fraser Forum;Nov2006, p25 

    The article reports on insurance coverage and innovation in the pharmaceutical industry. It cites the offsetting effects of the new public Medicare drug benefit being launched in the US. It asserts that through its natural risk-sharing features, insurance coverage stimulates the demand for the...

  • MANAGING MANY MEDS. Alaimo, Dan // SN: Supermarket News;6/4/2007, Vol. 55 Issue 23, p53 

    The article considers the use of Medication Therapy Management (MTM) in the U.S. to restore profits to pharmacies, while building customer loyalty. MTM came to prominence as a reimbursed service of the Medicare prescription drug benefit, which became effective January 1, 2006. Retailers report...

  • Healthcare Public Relations Shifts Gears. Green, Roselle // Public Relations Quarterly;Summer94, Vol. 39 Issue 2, p33 

    This article focuses on the opportunities offered by the emerging issues and trends in the healthcare industry to public relations practitioners in Canada. Healthcare services in Canada is gradually being redefined. Implicit in this redefinition is cost containment through reduced services and...

  • The impact of Part D on manufacturers. Lipowski, Earlene // Drug Topics;1/8/2007, Vol. 151 Issue 1, p30 

    The article discusses the benefits and impacts of Medicare Part D plan on Medicare beneficiaries and pharmaceutical manufacturers in the U.S. It mentioned that the benefit is seen to increase access to medication among, the government programs runs, risk of concentrating purchase power by...

  • Prospective Sectors for Investment: Healthcare and Pharmaceuticals. Blašković, Ivana; Mataić, Igor // Doing Business with Croatia;2005, p116 

    Presents information on the healthcare and pharmaceutical industry in Croatia. Life expectancy in Croatia as compared to some other European countries; Pharmaceutical pricing and reimbursement in the country; Information on the health reform project approved by the Croatian parliament.

  • LARGEST HEALTHCARE FRAUD SETTLEMENTS.  // Modern Healthcare;11/1/2010, Vol. 40 Issue 44, p33 

    No abstract available.


Read the Article


Sign out of this library

Other Topics